Free Trial
OTCMKTS:NWBO

Northwest Biotherapeutics (NWBO) Stock Price, News & Analysis

Northwest Biotherapeutics logo
$0.26 +0.00 (+1.11%)
As of 03:59 PM Eastern

About Northwest Biotherapeutics Stock (OTCMKTS:NWBO)

Key Stats

Today's Range
$0.26
$0.27
50-Day Range
$0.22
$0.29
52-Week Range
$0.17
$0.48
Volume
2.17 million shs
Average Volume
2.34 million shs
Market Capitalization
$387.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NWBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

NWBO Stock News Headlines

Northwest Biotherapeutics, Inc. (NWBO) - Yahoo Finance
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
NWBO Northwest Biotherapeutics, Inc. - Seeking Alpha
See More Headlines

NWBO Stock Analysis - Frequently Asked Questions

Northwest Biotherapeutics' stock was trading at $0.2748 at the beginning of the year. Since then, NWBO shares have decreased by 3.6% and is now trading at $0.2649.

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) posted its earnings results on Thursday, May, 15th. The biotechnology company reported ($0.01) earnings per share for the quarter. The biotechnology company earned $0.38 million during the quarter.

Shares of NWBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Northwest Biotherapeutics investors own include Clearside Biomedical (CLSD), Ocular Therapeutix (OCUL), Melinta Therapeutics (MLNT), NVIDIA (NVDA), Intel (INTC), Advanced Micro Devices (AMD) and Meta Platforms (META).

Company Calendar

Last Earnings
5/15/2025
Today
7/18/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:NWBO
Previous Symbol
NASDAQ:NWBO
CIK
1072379
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$83.78 million
Net Margins
-5,757.57%
Pretax Margin
-5,757.57%
Return on Equity
N/A
Return on Assets
-303.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.06
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$1.38 million
Price / Sales
279.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-3.77

Miscellaneous

Outstanding Shares
1,461,640,000
Free Float
1,331,699,000
Market Cap
$385.29 million
Optionable
Not Optionable
Beta
-1.12

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:NWBO) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners